Michael T. Flink, Ph.D. - Publications

Affiliations: 
2003 Michigan State University, East Lansing, MI 
Area:
Pharmacology

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Flink MT, Atchison WD. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies. Journal of Bioenergetics and Biomembranes. 35: 697-718. PMID 15000529 DOI: 10.1023/B:JOBB.0000008033.02320.10  1
2003 Flink MT, Atchison WD. Iberiotoxin-induced block of Ca2+-activated K+ channels induces dihydropyridine sensitivity of ACh release from mammalian motor nerve terminals. The Journal of Pharmacology and Experimental Therapeutics. 305: 646-52. PMID 12606686 DOI: 10.1124/jpet.102.046102  1
2002 Flink MT, Atchison WD. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission. The Journal of Physiology. 543: 567-76. PMID 12205190 DOI: 10.1113/jphysiol.2002.021048  1
Show low-probability matches.